<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0144">Therapeutic vaccination against HIV, HBV and other pathogens aims to reprogram the host's immune response to allow for better control of viral replication in the absence of therapy 
 <xref rid="JVEv5-bib-0055" ref-type="bibr">[55]</xref>. Dr Donn J Colby (Thai Red Cross AIDS Research Centre, Bangkok, Thailand) presented data from a trial in which the Ad26/MVA HIV-1 vaccine (recombinant adenovirus serotype 26 prime with a modified vaccinia Ankara boost â€“ US Military HIV-1 Research Program) was tested as a therapeutic vaccine in 18 acutely ART-treated individuals with nine participants in the placebo arm.
</p>
